Skip to main content
An official website of the United States government

Cancer Biomarkers

Promotes research to identify, develop, and validate biological markers for early cancer detection, risk prediction, and prevention. Supports development of collaborative databases and informatics systems, advancement of new technologies, and refinement of existing technologies.

On This Page

  • All Headings will automatically be pulled in to this list.
  • Do not edit the content on this template.

Major Programs

Staff List

Name, Email, Phone Room Group(s)/Office
Evans Williams, Felicia, M.B.A.
felicia.evanslong@nih.gov
240-276-5076
5E636 Program Analyst | Cancer Biomarkers
Fu, Sidney, M.D.
sidney.fu@nih.gov
240-276-6669
5E134 Program Officer | Cancer Biomarkers
Hodges, Nick, Ph.D.
nick.hodges@nih.gov
240-276-7844
5E616 Program Officer | Cancer Biomarkers
Kohaar, Indu, Ph.D., M.Phil., M.Sc.
indu.kohaar@nih.gov
240-620-0875
5E612 Program Officer | Cancer Biomarkers
Krueger, Karl, Ph.D. [V]
karl.krueger@nih.gov
Volunteer | Cancer Biomarkers
Marquez, Guillermo, Ph.D.
guillermo.marquez@nih.gov
240-276-7035
5E132 Program Officer | Cancer Biomarkers
Mazurchuk, Richard, Ph.D.
richard.mazurchuk@nih.gov
240-276-7126
5E582 Program Officer | Cancer Biomarkers
Orr, Susan
susan.orr@nih.gov
240-276-5001
5E626 Program Support Assistant | Cancer Biomarkers
Patriotis, Christos, Ph.D., M.Sc.
christos.patriotis@nih.gov
240-276-7134
5E614 Program Officer | Cancer Biomarkers
Petruzzelli, Angie
angie.petruzzelli@nih.gov
240-276-5076
5E624 Program Support Assistant | Cancer Biomarkers
Srivastava, Sudhir, Ph.D., M.P.H.
sudhir.srivastava@nih.gov
240-276-7028
5E136 Chief | Cancer Biomarkers
Wang, Wendy, Ph.D., M.Sc.
wendy.wang@nih.gov
240-276-7117
5E566 Program Officer | Cancer Biomarkers
Young, Matthew, Ph.D.
matthew.young@nih.gov
240-276-5846
5E610 Program Officer | Cancer Biomarkers

Grants

PI Name Sort descending PI Organization Title Grant Number Program Official
Singal, Amit

Ut Southwestern Medical Center
United States

Clinical Validation Center for Hepatocellular Carcinoma 5U01CA271887-03 Indu Kohaar, Ph.D., M.Phil., M.Sc.
Skates, Steven J

Massachusetts General Hospital
United States

Genome-wide methylation and proteomic analysis of uterine lavage and cervical swab for early detection of ovarian cancer 5U2CCA271871-02 Christos Patriotis, Ph.D., M.Sc.
Skubitz, Amy Patrice

University Of Minnesota
United States

A paradigm shift for ovarian cancer biomarkers: Utilizing routine Pap tests as liquid biopsies for the development of targeted mass spectrometry-based proteomic assays for early detection 5R01CA262153-04 Christos Patriotis, Ph.D., M.Sc.
Slager, Susan L

Mayo Clinic Rochester
United States

The genetic and epigenetic etiology of progression from the precursor state to chronic lymphocytic leukemia (CLL) 5R01CA258465-03
Spira, Avrum E

Boston University Medical Campus
United States

The Lung PCA: A Multi-Dimensional Atlas of Pulmonary Premalignancy 1U2CCA233238-01 Richard Mazurchuk, Ph.D.
Stachler, Matthew D

University Of California, San Francisco
United States

Optimization and validation of a biomarker panel for risk stratification in Barrett's esophagus 3R37CA269649-03S1 Matthew Young, Ph.D.
Storz, Peter

Mayo Clinic Jacksonville
United States

Deiminated molecules as markers for developing pancreatic cancer - A1 5R21CA279916-02 Matthew Young, Ph.D.
Sukumar, Saraswati

Johns Hopkins University
United States

Development of an automated, point of care DNA methylation cartridge blood test for colorectal cancer detection in LMICs- an academic-industrial partnership 5R01CA278816-03 Matthew Young, Ph.D.
Tanasova, Marina

Michigan Technological University
United States

Molecular probes for targeting facilitative fructose transporters (GLUTs) in biochemical and biomedical applications 2R15CA242401-02A1 Wendy Wang, Ph.D., M.Sc.
Tearney, Guillermo J

Massachusetts General Hospital
United States

Colorectal Cancer Screening with Optical Coherence Tomography 1R01CA280972-01A1 Matthew Young, Ph.D.
Thakur, Mathew Laxman

Thomas Jefferson University
United States

Noninvasive, Uniplex, Molecular, Pathomic Urinary Assay for Detection of Prostate Cancer 5R01CA249921-05 Richard Mazurchuk, Ph.D.
Tong, Frank

Vanderbilt University
United States

Learning the visual and cognitive bases of lung nodule detection 5R01CA240274-05 Richard Mazurchuk, Ph.D.
Torres, Keila Enitt

University Of Tx Md Anderson Can Ctr
United States

Use of Noninvasive Biomarkers and Advanced MRI for early detection of NF1-associated MPNSTs 5R01CA285980-02 Guillermo Marquez, Ph.D.
Velculescu, Victor E.

Johns Hopkins University
United States

DNA evaluation of fragments for early interception (DELFI) of Lung cancer 5U01CA271896-02 Guillermo Marquez, Ph.D.
Villanueva, Augusto

Icahn School Of Medicine At Mount Sinai
United States

Liquid biopsy and radiomics for liver cancer surveillance 5U01CA283931-02 Sidney Fu, M.D.